How to buy Synlogic stock | $2.64

Synlogic Inc is a biotechnology business based in the US. Synlogic shares (SYBX) are listed on the NASDAQ and all prices are listed in US Dollars. Synlogic employs 72 staff and has a trailing 12-month revenue of around 0.00.

Synlogic stock price (NASDAQ: SYBX)

Use our graph to track the performance of SYBX stocks over time.

Synlogic shares at a glance

• Key figures

Information last updated 2021-10-23.

Latest market close	$2.64
52-week range	$1.78 - $5.11
50-day moving average	$2.98
200-day moving average	$3.30
Wall St. target price	$9.80
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.36

Buy Synlogic shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Synlogic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Synlogic price performance over time

Historical closes compared with the close of $2.64 from 2021-10-26

1 week (2021-10-21)	-4.35%
1 month (2021-09-28)	-14.29%
3 months (2021-07-28)	-19.02%
6 months (2021-04-28)	-27.27%

1 year (2020-10-27)	38.22%
2 years (2019-10-25)	21.10%
3 years (2018-10-26)	8.1
5 years (2016-10-27)	104.65%

Synlogic financials

Revenue TTM	$246,000
Gross profit TTM	$545,000
Return on assets TTM	-22.8%
Return on equity TTM	-44.09%
Profit margin	0%
Book value	$2.45
Market capitalisation	$179.9 million

TTM: trailing 12 months

Shorting Synlogic shares

There are currently 573,968 Synlogic shares held short by investors – that's known as Synlogic's "short interest". This figure is 1.4% down from 582,230 last month.

There are a few different ways that this level of interest in shorting Synlogic shares can be evaluated.

Synlogic's "short interest ratio" (SIR)

Synlogic's "short interest ratio" (SIR) is the quantity of Synlogic shares currently shorted divided by the average quantity of Synlogic shares traded daily (recently around 940931.14754098). Synlogic's SIR currently stands at 0.61. In other words for every 100,000 Synlogic shares traded daily on the market, roughly 610 shares are currently held short.

However Synlogic's short interest can also be evaluated against the total number of Synlogic shares, or, against the total number of tradable Synlogic shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Synlogic's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Synlogic shares in existence, roughly 10 shares are currently held short) or 0.011% of the tradable shares (for every 100,000 tradable Synlogic shares, roughly 11 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Synlogic.

Find out more about how you can short Synlogic stock.

Synlogic share dividends

We're not expecting Synlogic to pay a dividend over the next 12 months.

Have Synlogic's shares ever split?

Synlogic's shares were split on a 1:7 basis on 27 August 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Synlogic shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Synlogic shares which in turn could have impacted Synlogic's share price.

Synlogic share price volatility

Over the last 12 months, Synlogic's shares have ranged in value from as little as $1.78 up to $5.11. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synlogic's is 1.5729. This would suggest that Synlogic's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Synlogic overview

Synlogic, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase II clinical trial to treat phenylketonuria (PKU), as well as pre-clinical stage product SYNB1934 for the treatment of PKU; and SYNB8802 that is in Phase I clinical trial for the treatment of Enteric Hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with Ginkgo Bioworks for the development of synthetic biotic medicines. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.

Frequently asked questions

What percentage of Synlogic is owned by insiders or institutions?
Currently 12.28% of Synlogic shares are held by insiders and 73.746% by institutions. How many people work for Synlogic?
Latest data suggests 72 work at Synlogic. When does the fiscal year end for Synlogic?
Synlogic's fiscal year ends in December. Where is Synlogic based?
Synlogic's address is: 301 Binney Street, Cambridge, MA, United States, 02142 What is Synlogic's ISIN number?
Synlogic's international securities identification number is: US87166L1008 What is Synlogic's CUSIP number?
Synlogic's Committee on Uniform Securities Identification Procedures number is: 60470J103